Boston Therapeutics (PK) Stock Price

-0.00011 (-0.42%)


52 Week Range


Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Boston Therapeutics Inc (PK) BTHE OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00011 -0.42% 0.02589 13:33:02
Open Price Low Price High Price Close Price Prev Close
0.026 0.017 0.026 0.026
Bid Price Ask Price Spread News
0.017 0.0259 0.0089 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9 19,995 $ 0.025663 $ 513 - 0.0055 - 0.067
Last Trade Time Type Quantity Stock Price Currency
13:42:46 1 $ 0.0259 USD


Draw Mode:

Boston Therapeutics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 23.74M 916.91M 43.38M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.80k $ - - - -

more financials information »

Boston Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTHE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0230.0260.0170.025761222,2330.0028912.57%
1 Month0.0229450.0260.015350.02044344,3980.0029512.84%
3 Months0.01910.03840.015350.0279681151,4700.0067935.55%
6 Months0.030.0670.01120.030608133,140-0.00411-13.7%
1 Year0.0170.0670.00550.0247305118,1970.0088952.29%
3 Years0.0530.07490.00520.024266379,570-0.02711-51.15%
5 Years0.050.170.00520.034126762,638-0.02411-48.22%

Boston Therapeutics (PK) Description

Boston Therapeutics, Inc. (OTCQB: BTHE), headquartered in Lawrence, MA, is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: BTI-320, a non-systemic chewable compound designed to reduce post-meal glucose elevation; IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia; and SUGARDOWN(R), an OTC dietary supplement designed to lower post-meal sugar spike. More information on BTHE is available at

Your Recent History
Boston The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.